Diseases requiring colonoscopy colonoscopy
Conditions
Interventions
None listed
Sponsors
Kanesaka Takashi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who undergo total colonoscopy at our institution. 2.Patients who receive a two-day split-dose regimen of Salprep oral solution as bowel preparation for colonoscopy. 3.Patients who have received sufficient explanation of the study and have provided written informed consent. 4.Patients aged 18 years or older. Individuals who meet all of the above criteria (1-4) will be considered eligible for inclusion.
Exclusion criteria
Exclusion criteria: 1.Patients with a history of gastrointestinal surgery. 2.Patients with suspected gastrointestinal obstruction or stenosis. 3.Patients with a history or suspicion of inflammatory bowel disease. 4.Patients with suspected intestinal perforation, toxic megacolon, or gastric emptying disorder. 5.Patients with severe renal dysfunction (creatinine clearance <30 mL/min). 6.Patients with a history of hypersensitivity to any component of the study medication. 7.Patients deemed inappropriate for inclusion by the attending physician. Individuals who meet any of the above criteria (1-7) will be considered ineligible for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Quality of bowel preparation before colonoscopy 2.Quality of intraluminal bowel preparation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Acceptability of the two-day split-dose bowel preparation regimen 2.Adverse events | — |
Contacts
Public ContactMuneshin Morita
Osaka International Cancer Institute
Outcome results
None listed